Categories
Topics

Fireside Chat with Vas Narasimhan, CEO of Novartis: The Future of Medicine and Leadership Insights

Deactivate selection mode Select images

The selection mode is now active. Click on the images you wish to download and choose an action below

Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation. Martin Vetterli, President of EPFL, and Vas Narasimhan, Chief Executive Officer of Novartis, on a series of topics including how AI is reshaping the future of medecine, insights into leadership and the key role Switzerland plays in research and innovation.